KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to -$148.0 million.

  • Moderna's Net Cash Flow rose 8225.42% to -$148.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$514.0 million, marking a year-over-year increase of 6067.33%. This contributed to the annual value of -$999.0 million for FY2024, which is 24567.47% down from last year.
  • Moderna's Net Cash Flow amounted to -$148.0 million in Q3 2025, which was up 8225.42% from -$346.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Net Cash Flow ranged from a high of $2.8 billion in Q1 2021 and a low of -$2.2 billion during Q2 2022
  • In the last 5 years, Moderna's Net Cash Flow had a median value of -$25.0 million in 2023 and averaged -$79.2 million.
  • Per our database at Business Quant, Moderna's Net Cash Flow skyrocketed by 170576.92% in 2021 and then tumbled by 145093.17% in 2022.
  • Quarter analysis of 5 years shows Moderna's Net Cash Flow stood at $1.3 billion in 2021, then crashed by 86.45% to $176.0 million in 2022, then plummeted by 114.2% to -$25.0 million in 2023, then skyrocketed by 1232.0% to $283.0 million in 2024, then crashed by 152.3% to -$148.0 million in 2025.
  • Its last three reported values are -$148.0 million in Q3 2025, -$346.0 million for Q2 2025, and -$303.0 million during Q1 2025.